KoKo

Focus: KoKo is a biotechnology company specializing in pulmonary functional testing and respiratory health solutions, founded in 2012 and based in Atlanta. The company operates with a focused product portfolio in respiratory care and adjacent therapeutic areas.

Respiratory

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About KoKo

AI assessmentNot Hiring

No open roles listed right now. Follow KoKo to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Full Sleep

Insomnia

N/A

Clinical Trials (1)

NCT05778812Online Insomnia Treatment Program

N/A

Help build intelligence for KoKo

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity at a 12-year-old biotech with established respiratory expertise and pulmonary testing domain knowledge
Diverse pipeline spanning respiratory, women's health (postpartum hemorrhage), and sleep medicine indicates strategic diversification
Atlanta location offers lower cost-of-living alternative to coastal biotech hubs with proximity to growing Southeast biotech corridor

Watch Out For

Zero active job openings signal potential hiring freeze, restructuring, or stagnation in workforce expansion
Minimal clinical development activity (2 trials total, no Phase 1-3 programs) suggests early-stage asset development or non-traditional commercial model
Complete absence of financial data, revenue figures, and funding information raises questions about company viability and growth trajectory

Generated by Claude from KoKo's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

KOKO Device

Postpartum Hemorrhage

N/A

Clinical Trials (1)

NCT06452355Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage

N/A

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2012

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo